Dezhan Health Care Co., Ltd. (000813)
XSHE XSHE Primary Summary
000813 Chart
Dezhan Health Care Co., Ltd. Dividends
| 0008 000813 1 Jun 2021 | Other | ¥0.21 Per Share |
Dezhan Health Care Co., Ltd. Earnings
| 8 May 2025 Date | | - Cons. EPS | - EPS |
| 8 May 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2016 Date | | - Cons. EPS | 0.28 EPS |
| 27 Aug 2016 Date | | - Cons. EPS | - EPS |
| 27 Apr 2016 Date | | - Cons. EPS | - EPS |
| 0008 000813 1 Jun 2021 | Other | ¥0.21 Per Share |
| 8 May 2025 Date | | - Cons. EPS | - EPS |
| 8 May 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2016 Date | | - Cons. EPS | 0.28 EPS |
| 27 Aug 2016 Date | | - Cons. EPS | - EPS |
| 27 Apr 2016 Date | | - Cons. EPS | - EPS |
Dezhan Health Care Co., Ltd. (000813) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Dezhan Health Care Co., Ltd. ever had a stock split?
Dezhan Health Care Co., Ltd. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Zheming Wei CEO | XSHE Exchange | CNE000000VV8 ISIN |
| CN Country | 1,054 Employees | - Last Dividend | 24 May 2017 Last Split | 9 Apr 1998 IPO Date |
Overview
Dezhan Healthcare Company Limited is a prominent entity in the pharmaceutical industry of the People's Republic of China, focusing on the research and development, manufacturing, and distribution of a wide variety of drugs primarily aimed at treating cardiovascular and cerebrovascular diseases. Since its establishment in 1980, the company has committed itself to producing high-quality medications to meet the health needs of the population and has significantly expanded its product line to include not only pharmaceuticals but also biological peptide products, food and beverages, cosmetics, and other health-related goods. Headquartered in Beijing, Dezhan Healthcare continues to innovate in the healthcare sector, contributing substantially to the local market with its vast array of products and services.
Products and Services
The diverse product range of Dezhan Healthcare encompasses several key areas within the pharmaceutical sector, embodying the company's dedication to heart and brain health, among other specialties. Below is an overview of their prominent offerings:
- Vastatin Calcium Tablets (Nile): A core product aimed at managing cholesterol levels, vital for patients with cardiovascular conditions.
- Trimetazidine Hydrochloride Capsules: These capsules are designed to improve myocardial glucose utilization, offering protection against ischemic heart disease.
- Fanle Type I and II Tablets: Tailored for patients with diabetes, these tablets help in managing blood sugar levels efficiently.
- Azathioprine Tablets: Primarily used in transplant medicine to prevent organ rejection and in some autoimmune diseases as an immunosuppressant.
- Amiodarone Hydrochloride Tablets: A critical medication for the treatment of arrhythmias, indicating the company's focus on comprehensive cardiovascular care.
- Hydroxyurea Tablets: Used in the treatment of certain cancers and sickle cell anemia, showcasing the company's role in catering to a broad spectrum of healthcare needs.
- Colchicine Tablets: Often prescribed for gout and familial Mediterranean fever, these tablets indicate the company's engagement in addressing less common but impactful health conditions.
In addition to pharmaceuticals, Dezhan Healthcare is actively involved in producing biological peptide products, further emphasizing its focus on innovative healthcare solutions. The company also diversifies its offerings into the food and beverage sector, cosmetics, and other health and wellness products, portraying a holistic approach to healthcare. Each product and service is a testament to Dezhan Healthcare's dedication to improving health outcomes and quality of life for individuals across the People's Republic of China.
Contact Information
